According to Inozyme Pharma's latest financial reports the company's current earnings (TTM) are -โน6.78 B. In 2023 the company made an earning of -โน5.45 B an increase over its 2022 earnings that were of -โน5.77 B.The earnings displayed on this page is the company's Pretax Income.